What’s the Difference Between Alzheimer’s and ‘Dementia’?

While many people use Alzheimer’s and dementia interchangeably, these don’t mean the same thing. So what exactly is the difference?  

Dementia is a set of symptoms: memory loss, problems with language, changes in behaviors, and difficulties with thinking or planning. A number of neurodegenerative diseases come with this set of symptoms. The most common is Alzheimer’s, which accounts for about seven in 10 cases of dementia

Alzheimer’s dementia involves memory loss and cognitive problems, which scientists understand to be connected somehow to deposits of toxic proteins in the brain, which get in the way of neuron activity and eventually lead to the death of brain cells. 

Other forms of dementia have similar symptoms, but different symptoms that appear first — and they might require different treatments. 

Here’s a quick look at the four most common kinds of dementia, including Alzheimer’s, vascular dementia, Lewy body dementia, and frontotemporal dementia.

Common types of dementia

Alzheimer’s disease

Many scientists think that Alzheimer’s disease is caused in part by the buildup of toxic protein plaques — amyloid and tau — which causes progressive cell death, memory loss, and thinking problems. There are many factors, including genes like APOE4, exercise, diabetes, and cardiovascular health, that can affect the risk of developing the disease.

Alzheimer’s is diagnosed by measuring the levels of amyloid in the brain using a brain scan or through a lumbar puncture, though blood tests are on the way. Some drugs are available to treat the cognitive and behavioral symptoms of the disease, and one drug called Leqembi can slow the course of the disease in the earliest stages.    

Vascular dementia

Vascular dementia is the second most common form of dementia. Damage to the brain’s blood vessels prevents nutrients and oxygen from getting to the brain, causing the cells to die. The symptoms will depend on where the blood vessels are damaged. For example, if it’s the blood vessels near the language region of the brain, a person with vascular dementia might develop problems with their speech. 

Vascular dementia shares cardiovascular risk factors with Alzheimer’s disease, like obesity, hypertension, and diabetes. People who experience strokes or heart disease are at an elevated risk of vascular dementia. Vascular dementia can be detected using an MRI brain scan, which can spot damaged blood vessels, alongside cognitive testing. There are currently no treatments for this form of dementia.

Frontotemporal dementia 

You might have heard of this form of dementia on the news: frontotemporal dementia (FTD). Bruce Willis has it. FTD often affects people between the ages of 50 and 60, causing parts of the brain important for language and understanding to die off. People with FTD often have a buildup of tau protein tangles and another misfolded protein called TDP-43 in their brain.

FTD may be more difficult to diagnose as there are no specific biomarkers. While some doctors may prescribe antidepressants off-label to treat some of the symptoms, scientists have not yet developed a treatment or cure for this disease.

Lewy body dementia

This form of dementia is caused by the buildup of a misfolded protein called alpha-synuclein in the brain, which causes progressive cell death. People first develop issues with thinking and then develop problems with moving. 

Like FTD, this dementia with Lewy bodies is challenging to diagnose because there aren’t any biomarkers. Getting the diagnosis right is important because some drugs used to treat behavioral symptoms in Alzheimer’s cause harmful side effects in people who have dementia with Lewy bodies.

A precision approach to zeroing in on a dementia

These different types of dementia can be very hard to tell apart. Misdiagnosis is common. And in the earliest stages of dementia — mild cognitive impairment — there are all kinds of things that could be causing cognitive symptoms. Sometimes, the cause is treatable

Right now, getting a precise diagnosis is difficult because there are many overlapping symptoms across dementias, and some people may develop multiple types at once. In the future, blood tests and PET scans might be able to tell the difference, making an early diagnosis accessible to everyone. Once scientists can more accurately diagnose people with these conditions, it will become possible to find the right drugs to treat each individual with dementia. 


Related Articles

Join a Study

If you are interested in learning more or participating in any of our studies, please fill out the form below and our office will get back to you within 1-2 business days. 

*By signing up you agree to be contacted about clinical research studies by our company, its affiliates or partners. Typical methods of contact include phone calls, text messages, pre-recorded messages, emails, automated technology or postal mail. This includes if the number is currently on any Do Not Call Lists. As we contact you, your electronic record will be updated accordingly with current relevant health information. This consent is not required to participate in a clinical research study.

Melissa Belardo, APRN

Clinical Investigator

Melissa Belardo, is a certified family nurse practitioner (FNP-BC), joins K2 Medical Research with more than a decade of clinical experience. She has served as an investigator in over 20 trials. Prior to clinical research, she held roles in gastroenterology, hepatology, and nurse education.

Melissa’s academic background includes a Bachelor of Science in Nursing from Adventist University, followed by a master’s degree in Family Nurse Practitioner from Georgetown University.

Melissa is a native of the US Virgin Islands’ and is fluent in both English and Spanish; Melissa has lived in central Florida for the past twenty years. When she’s not at work, you can find her volunteering at her local church and spending time with family.